< 1 minute read
Dec. 16, 2021
GSK852: a BET BD2 inhibitor
GSK852
1000x BD2-selective BET bromodomain inh. orally available in dog rational design from prior lead Journal of Medicinal Chemistry GlaxoSmithKline, Stevenage, UK
1000x BD2-selective BET bromodomain inh. orally available in dog rational design from prior lead Journal of Medicinal Chemistry GlaxoSmithKline, Stevenage, UK